Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Brian Smith

Showing results (201-210 of 280) with videos related to

Pageof 28
Sort By:
Early Human Development|August 26, 2018
Outcomes of preterm infants treated with hypothermia for hypoxic-ischemic encephalopathyTamara I Herrera, Laura Edwards, William F Malcolm, et al.
The Pediatric Infectious Disease Journal|May 16, 2018
Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical TrialsLaura L Kovanda, Thomas J Walsh, Daniel K Benjamin, et al.
Pediatrics|August 31, 2018
Pediatric Antibacterial and Antifungal Trials From 2007 to 2017Joshua T Thaden, Karen Chiswell, Ian Jaffe, et al.
Journal of Pediatric Intensive Care|November 17, 2022
Use of Electronic Health Records to Identify Exposure-Response Relationships in Critically Ill Children: An Example of Midazolam and DeliriumKanecia O Zimmerman, Tracy G Spears, Marjan Cobbaert, et al.
Annals of Human Biology|October 18, 2017
An anthropometric survey of US pre-term and full-term neonatesSusan M Abdel-Rahman, Ian M Paul, Paula Delmore, et al.
Pediatric Research|February 10, 2019
Prolonged duration of early antibiotic therapy in extremely premature infantsRachel G Greenberg, Dhuly Chowdhury, Nellie I Hansen, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2019
Rifampin Pharmacokinetics and Safety in Preterm and Term InfantsP Brian Smith, C Michael Cotten, Mark L Hudak, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation InitiativeRachel G Greenberg, Amy Corneli, John Bradley, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
External Evaluation of Two Fluconazole Infant Population Pharmacokinetic ModelsMichael F Hwang, Ryan J Beechinor, Kelly C Wade, et al.
The Pediatric Infectious Disease Journal|April 17, 2013
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infantsMichael Cohen-Wolkowiez, Mario Sampson, Barry T Bloom, et al.
Pageof 28

Showing results (201-210 of 280) with videos related to

Sort By:
Pageof 28
Early Human Development|August 26, 2018
Outcomes of preterm infants treated with hypothermia for hypoxic-ischemic encephalopathyTamara I Herrera, Laura Edwards, William F Malcolm, et al.
The Pediatric Infectious Disease Journal|May 16, 2018
Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical TrialsLaura L Kovanda, Thomas J Walsh, Daniel K Benjamin, et al.
Pediatrics|August 31, 2018
Pediatric Antibacterial and Antifungal Trials From 2007 to 2017Joshua T Thaden, Karen Chiswell, Ian Jaffe, et al.
Journal of Pediatric Intensive Care|November 17, 2022
Use of Electronic Health Records to Identify Exposure-Response Relationships in Critically Ill Children: An Example of Midazolam and DeliriumKanecia O Zimmerman, Tracy G Spears, Marjan Cobbaert, et al.
Annals of Human Biology|October 18, 2017
An anthropometric survey of US pre-term and full-term neonatesSusan M Abdel-Rahman, Ian M Paul, Paula Delmore, et al.
Pediatric Research|February 10, 2019
Prolonged duration of early antibiotic therapy in extremely premature infantsRachel G Greenberg, Dhuly Chowdhury, Nellie I Hansen, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2019
Rifampin Pharmacokinetics and Safety in Preterm and Term InfantsP Brian Smith, C Michael Cotten, Mark L Hudak, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation InitiativeRachel G Greenberg, Amy Corneli, John Bradley, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
External Evaluation of Two Fluconazole Infant Population Pharmacokinetic ModelsMichael F Hwang, Ryan J Beechinor, Kelly C Wade, et al.
The Pediatric Infectious Disease Journal|April 17, 2013
Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infantsMichael Cohen-Wolkowiez, Mario Sampson, Barry T Bloom, et al.
Pageof 28